The effect of spinal ropivacaine and bupivacaine on heart rate variability

NI Weiguo,ZHONG Taidi

DOI: https://doi.org/10.3969/j.issn.1672-3686.2006.05.012

2006-01-01

Abstract:Objective To assess the effect and safety of 0.5%spinal ropivacaine on heart rate variability. Methods Eighty ASA I-II patients scheduled for elective lower abdominal or lower limbs operations were randomized to receive 0.5%spinal ropivacaine (group R, n=40) or bupivacaine (group B, n=40). MAP, HR, LF, HF, LF/HF and TF were monitored and recorded before injection, at 5 min, 10 min and 20 min after injection. Results LF, TF and LF/HF in group R decreased together, and there were significant difference between the data at 10 min, 20 min after injection and baseline. MAP, LF, TF and LF/HF in group B also decreased, and there were significant changes between the data at 5 min after injection and baseline, and there were very significant changes between the data at 10 min, 20 min after injection and baseline. MAP, TF, LF and LF/HF at 5 min after injection in group B were significantly lower than those in group R. LF and LF/HF at 10 min and 20 min after injection in group B were very significantly lower than those in group R. HR and HF also reduced in both groups, but there were no significant difference compared with baseline. Conclusion 0.5%spinal ropivacaine is less effective than bupivacaine on heart rate variability, and it is safer than bupivacaine.